Lymphocytes sub-types and functions in centenarians as models for successful ageing

Handbook on Immunosenescence: Basic Understanding and Clinical Applications

Volumn 9781402090639, Issue , 2009, Pages 29-62

  Lugli, Enrico ^a   Troiano, Leonarda ^a   Pinti, Marcello ^a   Nasi, Milena ^a   Roat, Erika ^a   Ferraresi, Roberta ^a   Bertoncelli, Linda ^a   Gibellini, Lara ^a   Nemes, Elisa ^a   Cossarizza, Andrea ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950280006     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9063-9_2     Document Type: Chapter

References (210)

1. Franceschi C, Cossarizza A (1995) Introduction: the reshaping of the immune system with age. Int Rev Immunol, 12:1-4s
2. Allman D, Miller JP (2005) B-cell development and receptor diversity during aging. Curr Opin Immunol, 17:463-467
3. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol, 5:133-139
4. Wack A, Cossarizza A, Heltai S, Barbieri D, D'Addato S, Fransceschi C, Dellabona P, Casorati G (1998) Age-related modifications of the human alphabeta T-cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol, 10:1281-1288
5. Crawford J, Eye MK, Cohen HJ (1987) Evaluation of monoclonal gammopathies in the "well" elderly. Am J Med, 82:39-45
6. Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, Giacomelli T, Passeri G, Fagiolo U, Pinchera A, et al (1992) Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet, 339:1506-1508
7. Goronzy JJ, Weyand CM (2005) T-cell development and receptor diversity during aging. Curr Opin Immunol, 17:468-475
8. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafe M (1999) Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol, 34:911-921
9. Franceschi C, Bonafe M, Valensin S (2000) Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine, 18:1717-1720
10. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A (2005) Human immunosenescence: is it infectious? Immunol Rev, 205:257-268
11. George AJ, Ritter MA (1996) Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today, 17:267-272
12. Steinmann GG, Klaus B, Muller-Hermelink HK (1985) The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol, 22:563-575
13. Terszowski G, Muller SM, Bleul CC, Blum C, Schirmbeck R, Reimann J, Pasquier LD, Amagai T, Boehm T, Rodewald HR (2006) Evidence for a functional second thymus in mice. Science, 312:284-287
14. Swain S, Clise-Dwyer K, Haynes L (2005) Homeostasis and the age-associated defect of CD4 T-cells. Semin Immunol, 17:370-377
15. Kronenberg M, Rudensky A (2005) Regulation of immunity by self-reactive T-cells. Nature, 435:598-604
16. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T-cells in immunological tolerance to self and non-self. Nat Immunol, 6:345-352
17. von Boehmer H (2005) Mechanisms of suppression by suppressor T-cells. Nat Immunol, 6:338-344
18. Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol, 24:209-226
19. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Hopner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rotzschke O, Falk K (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 110:1225-1232
20. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E (2007) Cyclic adenosine monophosphate is a key component of regulatory T-cell-mediated suppression. J Exp Med, 204:1303-1310
21. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T-cells mediates immune suppression. J Exp Med, 204:1257-1265
22. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T-cells. J Exp Med, 203:1693-1700
23. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med, 203:1701-1711
24. Dejaco C, Duftner C, Schirmer M (2006) Are regulatory T-cells linked with aging? Exp Gerontol, 41:339-345
25. Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T-cells. J Exp Med, 199:1401-1408
26. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H (2005) Inducing and expanding regulatory T-cell populations by foreign antigen. Nat Immunol, 6:1219-1227
27. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E (2006) Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine, 34:32-38
28. Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA (2005) CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell, 4:291-298
29. Fagiolo U, Cossarizza A, Santacaterina S, Ortolani C, Monti D, Paganelli R, Franceschi C (1992) Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people. Ann N Y Acad Sci, 663:490-493
30. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R (1993) Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol, 23:2375-2378
31. Gerli R, Monti D, Bistoni O, Mazzone AM, Peri G, Cossarizza A, Di Gioacchino M, Cesarotti ME, Doni A, Mantovani A, Franceschi C, Paganelli R (2000) Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev, 121:37-46
32. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, Patel DD, Haynes BF (2000) Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol, 164:2180-2187
33. Cossarizza A, Ortolani C, Monti D, Franceschi C (1997) Cytometric analysis of immunosenescence. Cytometry, 27:297-313
34. Franceschi C, Monti D, Sansoni P, Cossarizza A (1995) The immunology of exceptional individuals: the lesson of centenarians. Immunol Today, 16:12-16
35. Paolisso G, Barbieri M, Bonafe M, Franceschi C (2000) Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest, 30:888-894
36. Cancro MP (2005) B-cells and aging: gauging the interplay of generative, selective, and homeostatic events. Immunol Rev, 205:48-59
37. Lopes-Carvalho T, Foote J, Kearney JF (2005) Marginal zone B-cells in lymphocyte activation and regulation. Curr Opin Immunol, 17:244-250
38. Pillai S, Cariappa A, Moran ST (2005) Marginal zone B cells. Annu Rev Immunol, 23:161-196
39. Boumsell L, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J (1978) Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T-cells. Eur J Immunol, 8:900-904
40. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA (1983) The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med, 157:202-218
41. Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol, 20:253-300
42. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W (1990) CD27 expression by a distinct subpopulation of human B-lymphocytes. Eur J Immunol, 20:2679-2684
43. Maurer D, Fischer GF, Fae I, Majdic O, Stuhlmeier K, Von Jeney N, Holter W, Knapp W (1992) IgM and IgG but not cytokine secretion is restricted to the CD27+ B-lymphocyte subset. J Immunol, 148:3700-3705
44. Agematsu K (2000) Memory B-cells and CD27. Histol Histopathol, 15:573-576
45. Agematsu K, Hokibara S, Nagumo H, Komiyama A (2000) CD27: a memory B-cell marker. Immunol Today, 21:204-206
46. Agematsu K, Kobata T, Sugita K, Freeman GJ, Beckmann MP, Schlossman SF, Morimoto C (1994) Role of CD27 in T-cell immune response. Analysis by recombinant soluble CD27. J Immunol, 153:1421-1429
47. Agematsu K, Nagumo H, Yang FC, Nakazawa T, Fukushima K, Ito S, Sugita K, Mori T, Kobata T, Morimoto C, Komiyama A (1997) B-cell subpopulations separated by CD27 and crucial collaboration of CD27+ B-cells and helper T-cells in immunoglobulin production. Eur J Immunol, 27:2073-2079
48. Shi Y, Agematsu K, Ochs HD, Sugane K (2003) Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B-cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol, 108:128-137
49. Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, Sansoni P, Pucillo LP, Scala E, Cozzi E, et al (1992) Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol, 90:351-354.
50. Colonna-Romano G, Aquino A, Bulati M, Di Lorenzo G, Listi F, Vitello S, Lio D, Candore G, Clesi G, Caruso C (2006) Memory B-cell subpopulations in the aged. Rejuvenation Res, 9:149-152
51. Colonna-Romano G, Bulati M, Aquino A, Scialabba G, Candore G, Lio D, Motta M, Malaguarnera M, Caruso C (2003) B-cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev, 124:389-393
52. Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K (2005) Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B-cell. J Immunol, 175:3262-3267
53. LeMaoult J, Manavalan JS, Dyall R, Szabo P, Nikolic-Zugic J, Weksler ME (1999) Cellular basis of B-cell clonal populations in old mice. J Immunol, 162:6384-6391
54. Kyle RA, Rajkumar SV (1999) Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am, 13:1181-1202
55. Merlini G, Farhangi M, Osserman EF (1986) Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. Semin Oncol, 13:350-365
56. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, Caligaris-Cappio F (2004) Monoclonal CD5+ and CD5-B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood, 103:2337-2342
57. Schwab R, Walters CA, Weksler ME (1989) Host defense mechanisms and aging. Semin Oncol, 16:20-27
58. Rowley MJ, Buchanan H, Mackay IR (1968) Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet, 2:24-26
59. Hallgren HM, Buckley CE 3rd, Gilbertsen VA, et al (1973) Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J Immunol, 111:1101-1107
60. De Greef GE, Van Tol MJ, Van Den Berg JW, Van Staalduinen GJ, Janssen CJ, Radl J, Hijmans W. (1992) Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans. Mech Ageing Dev, 66:29-44
61. Listi F, Candore G, Modica MA, Russo M, Di Lorenzo G, Esposito-Pellitteri M, Colonna-Romano G, Aquino A, Bulati M, Lio D, Franceschi C, Caruso C (2006) A study of serum immunoglobulin levels in elderly persons that provides new insights into B-cell immunosenescence. Ann NY Acad Sci, 1089:487-495
62. Cossarizza A, Ortolani C, Paganelli R Barbieri D, Monti D, Sansoni P, Fagiolo U, Castellani G, Bersani F, Londei M, Franceschi C (1996) CD45 isoforms expression on CD4+ and CD8 +T-cells throughout life, from newborns to centenarians: implications for T-cell memory. Mech Ageing Dev, 86:173-195
63. Miller RA (1996) The aging immune system: primer and prospectus. Science, 273:70-74
64. Nociari MM, Telford W, Russo C (1999) Postthymic development of CD28-CD8+ T-cell subset: age-associated expansion and shift from memory to naive phenotype. J Immunol, 162:3327-3335
65. Okumura M, Fujii Y, Takeuchi Y, Inada K, Nakahara K, Matsuda H (1993) Age-related accumulation of LFA-1high cells in a CD8+CD45RAhigh T-cell population. Eur J Immunol, 23:1057-1063
66. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature, 401:708-712
67. Lanzavecchia A, Sallusto F (2005) Understanding the generation and function of memory T-cell subsets. Curr Opin Immunol, 17:326-332
68. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P (2000) Shortage of circulating naive CD8 (+) T-cells provides new insights on immunodeficiency in aging. Blood, 95:2860-2868
69. De Rosa SC, Herzenberg LA, Roederer M (2001) 11-color, 13-parameter flow cytometry: identification of human naive T-cells by phenotype, function, and T-cell receptor diversity. Nat Med, 7:245-248
70. Lugli E, Pinti M, Nasi M, Troiano L, Ferraresi R, Mussi C, Salvioli G, Patsekin V, Robinson JP, Durante C, Cocchi M, Cossarizza A (2007) Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry A, 71:334-344
71. Nasi M, Troiano L, Lugli E, Pinti M, Ferraresi R, Monterastelli E, Mussi C, Salvioli G, Franceschi C, Cossarizza A (2006) Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell, 5:167-175
72. Hamann D, Kostense S, Wolthers KC, Otto SA, Baars PA, Miedema F, van Lier RA (1999) Evidence that human CD8+CD45RA+CD27-cells are induced by antigen and evolve through extensive rounds of division. Int Immunol, 11:1027-1033
73. Merino J, Martinez-Gonzalez MA, Rubio M, Inoges S, Sanchez-Ibarrola A, Subira ML (1998) Progressive decrease of CD8high+ CD28+ CD57-cells with ageing. Clin Exp Immunol, 112:48-51
74. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher H, Pawelec G (2003) Age-associated accumulation of CMV-specific CD8+ T-cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol, 38:911-920
75. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP (2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol, 18:529-560
76. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature, 396:690-695
77. Ma A, Koka R, Burkett P (2006) Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol, 24:657-679
78. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity, 9:669-676
79. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ (2000) Reversible defects in natural killer and memory CD8 T-cell lineages in interleukin 15-deficient mice. J Exp Med, 191:771-780
80. Kim HR, Hong MS, Dan JM, Kang I (2006) Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood, 107:2855-2862
81. Gangemi S, Basile G, Monti D, Merendino RA, Di Pasquale G, Bisignano U, Nicita-Mauro V, Franceschi C (2005) Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm,: 245-247
82. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ (2005) The influence of age on T-cell generation and TCR diversity. J Immunol, 174:7446-7452
83. Wallace DL, Zhang Y, Ghattas H, Worth A, Irvine A, Bennett AR, Griffin GE, Beverley PC, Tough DF, Macallan DC (2004) Direct measurement of T-cell subset kinetics in vivo in elderly men and women. J Immunol, 173:1787-1794
84. Geginat J, Lanzavecchia A, Sallusto F (2003) Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood, 101:4260-4266
85. Weng NP (2006) Aging of the immune system: how much can the adaptive immune system adapt? Immunity, 24:495-499
86. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL (1999) Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T-cells from naive T-cells of aged mice. J Exp Med, 190:1013-1024
87. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L (2004) Age-related defects in CD4 T-cell cognate helper function lead to reductions in humoral responses. J Exp Med, 200:1613-1622
88. Cossarizza A, Monti D, Bersani F, Paganelli R, Montagnani G, Cadossi R, Cantini M, Franceschi C (1989) Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects. FEBS Lett, 248:141-144
89. Witkowski JM, Li SP, Gorgas G, Miller RA (1994) Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T-cell subsets that differ in IL-2-driven IL-4 production. J Immunol, 153:658-665
90. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ranberg K, Schroll M, Jeune B (2003) High circulating levels of tumor necrosis factor-alpha in centenarians are not associated with increased production in T-lymphocytes. Gerontology, 49:155-160
91. Koch S, Solana R, Dela Rosa O, Pawelec G (2006) Human cytomegalovirus infection and T-cell immunosenescence: a mini review. Mech Ageing Dev, 127:538-543
92. Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franceschi C, Sansoni P (2004) Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T-cells. Exp Gerontol, 39:1233-1243
93. Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA (2004) Herpesvirus-specific CD8 T-cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol, 173:7481-7489
94. Sansoni P, Fagnoni F, Vescovini R, Mazzola M, Brianti V, Bologna G, Nigro E, Lavagetto G, Cossarizza A, Monti D, Franceschi C, Passeri M (1997) T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians. Mech Ageing Dev, 96:127-136
95. Franceschi C, Monti D, Cossarizza A, Fagnoni F, Passeri G, Sansoni P (1991) Aging, longevity, and cancer: studies in Down's syndrome and centenarians. Ann N Y Acad Sci, 621:428-440.
96. Bellavia D, Frada G, Di Franco P, Feo S, Franceschi C, Sansoni P, Brai M (1999) C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians. A Biol Sci Med Sci, 54:B150-B153
97. Mondello C, Petropoulou C, Monti D, Gonos ES, Franceschi C, Nuzzo F (1999) Telomere length in fibroblasts and blood cells from healthy centenarians. Exp Cell Res, 248:234-242
98. Scola L, Candore G, Colonna-Romano G, Crivello A, Forte GI, Paolisso G, Franceschi C, Lio D, Caruso C (2005) Study of the association with -330T/G IL-2 in a population of centenarians from centre and south Italy. Biogerontology, 6:425-429
99. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev, 121:187-201
100. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol, 37:445-453
101. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S, Nilsson BO, Ernerudh J, Pawelec G, Johansson B (2005) An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci, 60:556-565
102. Callahan JE, Kappler JW, Marrack P (1993) Unexpected expansions of CD8-bearing cells in old mice. J Immunol, 151:6657-6669
103. Clambey ET, van Dyk LF, Kappler JW, Marrack P (2005) Non-malignant clonal expansions of CD8+ memory T-cells in aged individuals. Immunol Rev, 205:170-189
104. Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G (2003) Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol, 23:247-257
105. Akbar AN, Fletcher JM (2005) Memory T-cell homeostasis and senescence during aging. Curr Opin Immunol, 17:480-485.
106. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155:1151-1164
107. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4 +T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389:737-742
108. Kim JM, Rudensky A (2006) The role of the transcription factor Foxp3 in the development of regulatory T-cells. Immunol Rev, 212:86-98
109. Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T-cell lineage. Nat Immunol, 8:457-462
110. Bluestone JA, Abbas AK (2003) Natural versus adaptive regulatory T-cells. Nat Rev Immunol, 3:253-257
111. Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, Whitham RH, Bakke A, Jones RE, Offner H, Bourdette DN, Vandenbark AA (2003) Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res, 74:296-308
112. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, Nayak L, Moss PA (2005) The number of human peripheral blood CD4+ CD25high regulatory T-cells increases with age. Clin Exp Immunol, 140:540-546
113. Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A (2006) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK-cells in humans-impact of immunosenescence. Clin Immunol, 119:307-316
114. Sharma S, Dominguez AL, Lustgarten J (2006) High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol, 177:8348-8355
115. Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S (2006) CD4+CD25+Foxp3+ T-cells and CD4+CD25-Foxp3+ T-cells in aged mice. J Immunol, 176:6586-6593
116. Shimizu J, Moriizumi E (2003) CD4+CD25-T-cells in aged mice are hyporesponsive and exhibit suppressive activity. J Immunol, 170:1675-1682
117. Moser B, Eberl M (2007) gammadelta T-cells: novel initiators of adaptive immunity. Immunol Rev, 215:89-102
118. Morita CT, Mariuzza RA, Brenner MB (2000) Antigen recognition by human gamma delta T-cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol, 22:191-217
119. Hayday AC (2000) [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol, 18:975-1026
120. Nanno M, Shiohara T, Yamamoto H, Kawakami K, Ishikawa H (2007) gammadelta T-cells: firefighters or fire boosters in the front lines of inflammatory responses. Immunol Rev, 215:103-113
121. Hintz M, Reichenberg A, Altincicek B, Bahr U, Gschwind RM, Kollas AK, Beck E, Wiesner J, Eberl M, Jomaa H (2001) Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T-cells in Escherichia coli. FEBS Lett, 509:317-322
122. Reichenberg A, Hintz M, Kletschek Y, Kuhl T, Haug C, Engel R, Moll J, Ostrovsky DN, Jomaa H, Eberl M (2003) Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human gammadelta T-cells but does not lead to competitive antagonism. Bioorg Med Chem Lett, 13:1257-1260
123. Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M, Monsarrat B, Saulquin X, Maillet S, Esteve JP, Lopez F, Perret B, Collet X, Bonneville M, Champagne E (2005) Tumor recognition following Vgamma9Vdelta2 T-cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity, 22:71-80
124. Chen ZW, Letvin NL (2003) Vgamma2Vdelta2+ T-cells and anti-microbial immune responses. Microbes Infect, 5:491-498
125. Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L, Kou Z, Wang Q, Jiang L, Estep J, Hunt R, Clagett M, Sehgal PK, Li Y, Zeng X, Morita CT, Brenner MB, Letvin NL, Chen ZW (2002) Adaptive immune response of Vgamma2Vdelta2+ T-cells during mycobacterial infections. Science, 295:2255-2258
126. Shin S, El-Diwany R, Schaffert S, Adams EJ, Garcia KC, Pereira P, Chien YH (2005) Antigen recognition determinants of gammadelta T-cell receptors. Science, 308:252-255
127. De Rosa SC, Andrus JP, Perfetto SP, Mantovani JJ, Herzenberg LA, Roederer M (2004) Ontogeny of gamma delta T-cells in humans. J Immunol, 172:1637-1645
128. Masopust D, Vezys V, Marzo AL, Lefrancois L (2001) Preferential localization of effector memory cells in nonlymphoid tissue. Science, 291:2413-2417
129. Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human gammadelta T-Cells. Science, 309:264-268
130. Argentati K, Re F, Donnini A, Tucci MG, Franceschi C, Bartozzi B, Bernardini G, Provinciali M (2002) Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J Leukoc Biol, 72:65-71
131. Colonna-Romano G, Aquino A, Bulati M, Lio D, Candore G, Oddo G, Scialabba G, Vitello S, Caruso C (2004) Impairment of gamma/delta T lymphocytes in elderly: implications for immunosenescence. Exp Gerontol, 39:1439-1446
132. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC (2001) Regulation of cutaneous malignancy by gammadelta T-cells. Science, 294:605-609
133. Groh V, Steinle A, Bauer S, Spies T (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T-cells. Science, 279:1737-1740
134. Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF (1999) Implication of gammadelta T-cells in the human immune response to cytomegalovirus. J Clin Invest, 103:1437-1449
135. Sciammas R, Bluestone JA (1999) TCRgammadelta cells and viruses. Microbes Infect, 1:203-212
136. Dieli F, Troye-Blomberg M, Farouk SE, Sireci G, Salerno A (2001) Biology of gammadelta T-cells in tuberculosis and malaria. Curr Mol Med, 1:437-446
137. Ramsburg E, Tigelaar R, Craft J, Hayday A (2003) Age-dependent requirement for gammadelta T-cells in the primary but not secondary protective immune response against an intestinal parasite. J Exp Med, 198:1403-1414
138. Caccamo N, Dieli F, Wesch D, Jomaa H, Eberl M (2006) Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T-cells. J Leukoc Biol, 79:663-666
139. Budzynski W, Radzikowski C (1994) Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol, 16:319-346
140. Lanier LL, Yu G, Phillips JH (1989) Coassociation of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature, 342:803-805
141. Nakazawa T, Agematsu K, Yabuhara A (1997) Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology, 92:180-187
142. Griffiths GM (2003) Endocytosing the death sentence. J Cell Biol, 160:155-156
143. Trapani JA (1998) Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. Int Rev Cytol, 182:111-192
144. Solana R, Mariani E (2000) NK and NK/T-cells in human senescence. Vaccine, 18:1613-1620
145. Kutza J, Murasko DM (1994) Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Cell Immunol, 155:195-204
146. Ogata K, Yokose N, Tamura H, An E, Nakamura K, Dan K, Nomura T (1997) Natural killer cells in the late decades of human life. Clin Immunol Immunopathol, 84:269-275
147. Ogata K, An E, Shioi Y, Nakamura K, Luo S, Yokose N, Minami S, Dan K (2001) Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol, 124:392-397
148. Pawelec G, Solana R, Remarque E, Mariani E (1998) Impact of aging on innate immunity. J Leukoc Biol, 64:703-712
149. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK (2001) Decreased natural killer cell activity is associated with atherosclerosis in elderly humans. Exp Gerontol, 37:127-136
150. Mysliwska J, Trzonkowski P, Szmit E, Brydak LB, Machala M, Mysliwski A (2004) Immunomodulating effect of influenza vaccination in the elderly differing in health status. Exp Gerontol, 39:1447-1458
151. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E, et al (1993) Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood, 82:2767-2773
152. Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B, Pena J, Solana R (1999) NK phenotypic markers and IL2 response in NK-cells from elderly people. Exp Gerontol, 34:253-265
153. Lutz CT, Moore MB, Bradley S, Shelton BJ, Lutgendorf SK (2005) Reciprocal age related change in natural killer cell receptors for MHC class I. Mech Ageing Dev, 126:722-731
154. Mariani E, Monaco MC, Cattini L, Sinoppi M, Facchini A (1994) Distribution and lytic activity of NK cell subsets in the elderly. Mech Ageing Dev, 76:177-187
155. Mariani E, Sgobbi S, Meneghetti A, Tadolini M, Tarozzi A, Sinoppi M, Cattini L, Facchini A (1996) Perforins in human cytolytic cells: the effect of age. Mech Ageing Dev, 92:195-209
156. Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, Glavas M, Christmas SE, Podack ER (1998) Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood, 92:2410-2420
157. Franceschi C, Motta L, Valensin S, Rapisarda R, Franzone A, Berardelli M, Motta M, Monti D, Bonafe M, Ferrucci L, Deiana L, Pes GM, Carru C, Desole MS, Barbi C, Sartoni G, Gemelli C, Lescai F, Olivieri F, Marchegiani F, Cardelli M, Cavallone L, Gueresi P, Cossarizza A, Troiano L, Pini G, Sansoni P, Passeri G, Lisa R, Spazzafumo L, Amadio L, Giunta S, Stecconi R, Morresi R, Viticchi C, Mattace R, De Benedictis G, Baggio G (2000) Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano), 12:77-84
158. Rink L, Cakman I, Kirchner H (1998) Altered cytokine production in the elderly. Mech Ageing Dev, 102:199-209
159. Murasko DM, Jiang J (2005) Response of aged mice to primary virus infections. Immunol Rev, 205:285-296
160. Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, Facchini A (2002) Chemokine production by natural killer cells from nonagenarians. Eur J Immunol, 32:1524-1529
161. Kelley KW, Weigent DA, Kooijman R (2007) Protein hormones and immunity. Brain Behav Immun, 21:384-392
162. Straub RH, Cutolo M (2001) Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum, 44:493-507
163. Mocchegiani E, Giacconi R, Muti E, Rogo C, Bracci M, Muzzioli M, Cipriano C, Malavolta M (2004) Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann NY Acad Sci, 1019:127-134
164. Mocchegiani E, Malavolta M (2004) NK and NKT cell functions in immunosenescence. Aging Cell, 3:177-184
165. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, Maioli F, Boschi F, Pratelli L, Pizzoferrato A, Piras F, Facchini A (1999) Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol, 116:19-27
166. Miyaji C, Watanabe H, Toma H, Akisaka M, Tomiyama K, Sato Y, Abo T (2000) Functional alteration of granulocytes, NK-cells, and natural killer T-cells in centenarians. Hum Immunol, 61:908-916
167. Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaetti R, Cavalieri E, Suzuki H (2003) Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev, 124:459-468
168. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T-cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha/beta T-cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med, 178:1-16
169. Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, Gaschet J, Costa P, Jacques Y, Godard A, Vie H, Poggi A, Romagne F, Bonneville M (1997) Close phenotypic and functional similarities between human and murine alphabeta T-cells expressing invariant TCR alpha-chains. J Immunol, 158:5603-5611
170. Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M (1995) Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T-cell populations. Int Immunol, 7:1157-1161
171. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H (2003) The regulatory role of Valpha14 NKT-cells in innate and acquired immune response. Annu Rev Immunol, 21:483-513
172. Prussin C, Foster B (1997) TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T-cell analog containing a unique Th0 subpopulation. J Immunol, 159:5862-5870
173. Brigl M, Brenner MB (2004) CD1: antigen presentation and T-cell function. Annu Rev Immunol, 22:817-890
174. Bendelac A, Rivera MN, Park SH, et al (1997) Mouse CD1-specific NK1 T-cells: development, specificity, and function. Annu Rev Immunol, 15:535-562
175. Zhou D, Mattner J, Cantu C, 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004) Lysosomal glycosphingolipid recognition by NKT-cells. Science, 306:1786-1789
176. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T-cells. Nature, 434:520-525
177. Zajonc DM, Maricic I, Wu D, Halder R, Roy K, Wong CH, Kumar V, Wilson IA (2005) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med, 202:1517-1526
178. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT-cells during microbial infections. Nature, 434:525-529
179. Kim CH, Butcher EC, Johnston B (2002) Distinct subsets of human Valpha24-invariant NKT-cells: cytokine responses and chemokine receptor expression. Trends Immunol, 23:516-519
180. Lee PT, Benlagha K, Teyton L, Bendelac A (2002) Distinct functional lineages of human V (alpha) 24 natural killer T-cells. J Exp Med, 195:637-641
181. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T-cells revealed by CD1d tetramer staining. J Exp Meds, 195:625-636
182. D'Andrea A, Goux D, De Lalla C, Koezuka Y, Montagna D, Moretta A, Dellabona P, Casorati G, Abrignani S (2000) Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur J Immunol, 30:1544-1550
183. Sandberg JK, Bhardwaj N, Nixon DF (2003) Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol, 33:588-596
184. Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat Rev Immunol, 7:505-518
185. Seino K, Taniguchi M (2004) Functional roles of NKT cell in the immune system. Front Biosci, 9:2577-2587
186. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT-cells. J Clin Invest, 114:1379-1388
187. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T (1999) The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT-cells. J Exp Med, 189:1121-1128
188. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, Akutsu Y, Motohashi S, Iizasa T, Endo H, Fujisawa T, Shinkai H, Taniguchi M (1999) Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT-cells. Cancer Res, 59:5102-5105
189. Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K, Abraham R, Juji T, Macfarlane DJ, Nicol AJ (2004) Therapeutic activation of Valpha24+Vbeta11+ NKT-cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103:383-389
190. Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol, 23:877-900
191. Linsen L, Somers V, Stinissen P (2005) Immunoregulation of autoimmunity by natural killer T-cells. Hum Immunol, 66:1193-1202
192. MacDonald HR (2002) Development and selection of NKT-cells. Curr Opin Immunol, 14:250-254
193. McNerlan SE, Rea IM, Alexander HD, Morris TC (1998) Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol, 18:31-38
194. Miyaji C, Watanabe H, Minagawa M, Toma H, Kawamura T, Nohara Y, Nozaki H, Sato Y, Abo T (1997) Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol, 17:420-429
195. Dela Rosa O, Tarazona R, Casado JG, Alonso C, Ostos B, Pena J, Solana R (2002) Valpha24+ NKT-cells are decreased in elderly humans. Exp Gerontol, 37:213-217
196. Crough T, Purdie DM, Okai M, Maksoud A, Nieda M, Nicol AJ (2004) Modulation of human Valpha24 (+) Vbeta11 (+) NKT-cells by age, malignancy and conventional anticancer therapies. Br J Cancer, 91:1880-1886
197. Molling JW, Kolgen W, Van Der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, Van Den Eertwegh AJ (2005) Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer, 116:87-93
198. Peralbo E, Delarosa O, Gayoso I, Pita ML, Tarazona R, Solana R (2006) Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology, 7:483-492
199. Jing Y, Gravenstein S, Rao Chaganty N, Chen N, Lyerly KH, Joyce S, Deng Y (2007) Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT-cells from human peripheral blood. Exp Gerontol
200. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT-cells: what's in a name? Nat Rev Immunol, 4:231-237
201. Tarazona R, Dela Rosa O, Alonso C, Ostos B, Espejo J, Pena J, Solana R (2000) Increased expression of NK cell markers on T-lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T-cells. Mech Ageing Dev, 121:77-88
202. Abedin S, Michel JJ, Lemster B, Vallejo AN (2005) Diversity of NKR expression in aging T-cells and in T-cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol, 40:537-548
203. Berzins SP, Uldrich AP, Pellicci DG, McNab F, Hayakawa Y, Smyth MJ, Godfrey DI (2004) Parallels and distinctions between T and NKT cell development in the thymus. Immunol Cell Biol, 82:269-275
204. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A (2005) Characterization of the early stages of thymic NKT cell development. J Exp Med, 202:485-492
205. Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, Hennighausen L, Bendelac A, Littman DR (2005) Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity, 22:705-716
206. Forsey RJ, Thompson JM, Ernerudh J, Hurst TL, Strindhall J, Johansson B, Nilsson BO, Wikby A (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev, 124:487-493
207. De Martinis M, Modesti M, Ginaldi L (2004) Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from elderly persons. Immunol Cell Biol, 82:415-420
208. Perfetto SP, Chattopadhyay PK, Roederer M (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol, 4:648-655
209. Lugli E, Troiano L, Cossarizza A. Investigating T cells by polychromatic flow cytometry. T cell protocols: Second edition, Vol. 54. G. De Libero Ed. Humana Press, 2009 (in press)
210. Clambey ET, Kappler JW, Marrack P (2007) CD8 T-cell clonal expansions & aging: a heterogeneous phenomenon with a common outcome. Exp Gerontol, 42:407-411